Skip to main content

RITHOLTZ WEALTH MANAGEMENT

Position in ZTS — Zoetis Inc.

CIK 1698218 NEW YORK, NY

Position in ZTS

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$1,163,422
+$78,980 QoQ
Shares Held
9,842
+14.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0.6604348709611868.ToString("F0")% Shared 0.ToString("F0")% None 99.3395651290388.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2021
CallValue
$47,244
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RITHOLTZ WEALTH MANAGEMENT holds $15,325,288 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ZTS
Zoetis Inc.
This page
9,842 $1,163,422

All Filings in ZTS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,163,422 9,842
2025-12-31 $1,084,442 8,619
2025-09-30 $2,850,898 19,484
2025-06-30 $3,543,963 22,725
2025-03-31 $3,467,858 21,062
2024-12-31 $3,203,529 19,662
2024-09-30 $3,869,500 19,805
2024-06-30 $3,445,183 19,873
2024-03-31 $3,624,647 21,421
2023-12-31 $4,260,231 21,585
2023-09-30 $3,868,793 22,237
2023-06-30 $3,299,715 19,161
2023-03-31 $3,585,949 21,545
2022-12-31 $2,359,601 16,101
2022-09-30 $1,763,612 11,893
2022-06-30 $936,456 5,448
2022-03-31 $981,988 5,207
2021-12-31 $907,791 3,720
2021-09-30 $658,134 3,390
2021-06-30 $577,529 3,099
2021-03-31 $398,739 2,532
2021-03-31 $47,244 300
2020-12-31 $415,074 2,508
2020-09-30 $383,493 2,319
2020-06-30 $255,990 1,868